Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.54 | -$0.41 | -$0.48 |
| Q2 2026 | 1 | -$0.42 | -$0.36 | -$0.39 |
| Q3 2026 | 1 | -$0.32 | -$0.31 | -$0.32 |
| Q4 2026 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q1 2027 | 1 | -$0.34 | -$0.33 | -$0.34 |
| Q2 2027 | 1 | -$0.28 | -$0.27 | -$0.28 |
| Q3 2027 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2027 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q1 2028 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2028 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2028 | 1 | -$0.09 | -$0.09 | -$0.09 |
Twist Bioscience Corp last posted its earnings results on Monday, February 2nd, 2026. The company reported $-0.5 earnings per share for the quarter, missing analysts' consensus estimates of $-0.48 by $0.02. The company had revenue of 103.70 M for the quarter and had revenue of 376.57 M for the year. Twist Bioscience Corp has generated $-1 earnings per share over the last year ($-1.3 diluted earnings per share) and currently has a price-to-earnings ratio of -41.86. Twist Bioscience Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/02/2026 | Q1 2026 | -$0.48 | -$0.50 | -0.02 | $101.88 M | $103.70 M |
| 11/17/2025 | Q4 2025 | N/A | -$0.45 | N/A | $97.33 M | $99.01 M |
| 08/04/2025 | Q3 2025 | -$0.54 | $0.34 | 0.88 | $95.61 M | $96.06 M |
| 05/05/2025 | Q2 2025 | -$0.56 | -$0.66 | -0.1 | $91.99 M | $92.79 M |
| 02/03/2025 | Q1 2025 | -$0.62 | -$0.53 | 0.09 | $86.96 M | $88.71 M |
| 11/18/2024 | Q4 2024 | -$0.71 | -$0.60 | 0.11 | $82.71 M | $84.71 M |
| 08/02/2024 | Q3 2024 | -$0.79 | -$1.47 | -0.68 | $77.40 M | $81.46 M |
| 05/02/2024 | Q2 2024 | -$0.84 | -$0.79 | 0.05 | $70.70 M | $75.30 M |
| 02/02/2024 | Q1 2024 | -$0.80 | -$0.75 | 0.05 | N/A | $71.50 M |
| 11/21/2023 | Q4 2023 | N/A | -$0.81 | N/A | N/A | $66.95 M |
| 08/07/2023 | Q3 2023 | N/A | -$1.01 | N/A | N/A | $63.74 M |
| 05/08/2023 | Q2 2023 | N/A | -$1.04 | N/A | N/A | $60.18 M |
| 02/07/2023 | Q1 2023 | N/A | -$0.74 | N/A | N/A | $54.24 M |
| 06/05/2023 | Q4 2022 | N/A | -$0.91 | N/A | N/A | $57.31 M |
| 08/08/2022 | Q3 2022 | N/A | -$1.08 | N/A | N/A | $56.11 M |
| 05/06/2022 | Q2 2022 | N/A | -$1.13 | N/A | N/A | $48.13 M |
| 02/09/2022 | Q1 2022 | N/A | -$0.91 | N/A | N/A | $42.02 M |
| 11/22/2021 | Q4 2021 | N/A | -$0.84 | N/A | N/A | $37.95 M |
| 08/09/2021 | Q3 2021 | N/A | -$0.82 | N/A | N/A | $35.02 M |
| 05/07/2021 | Q2 2021 | N/A | -$0.78 | N/A | N/A | $31.20 M |
The conference call for Twist Bioscience Corp's latest earnings report can be listened to online.
The conference call transcript for Twist Bioscience Corp's latest earnings report can be read online.
Twist Bioscience Corp (:TWST) has a recorded annual revenue of $376.57 M.
Twist Bioscience Corp (:TWST) has a recorded net income of $-77,670,000.Twist Bioscience Corp has generated $-1.3 earnings per share over the last four quarters.
Twist Bioscience Corp (:TWST) has a price-to-earnings ratio of -41.86 and price/earnings-to-growth ratio is -18.14.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED